Access cutting-edge alzheimer's disease treatment through this clinical trial at a research site in Redlands. Study-provided care at no cost to qualified participants.
Access alzheimer's disease specialists in Redlands at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alzheimer's disease treatment provided free
Researchers want to learn if giving MK-1167 (the study medicine) along with acetylcholinesterase inhibitor (AChEI) therapy can improve symptoms of Alzheimer's disease dementia (AD dementia), such as memory and mental activity. AD dementia is the most common type of dementia. AChEI therapy is the standard treatment for AD dementia. The goals of this study are to learn: * If at least one dose level (amount) of MK-1167 works to improve a person's memory and thinking compared to a placebo * About
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this alzheimer's disease clinical trial in Redlands, CA
If you're searching for alzheimer's disease treatment options in Redlands, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Redlands research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.